FOX04-DRI 5mg

OVERVIEW

Advance your laboratory research with FOX04-DRI (5mg), a premium research-grade peptide available from Titan Peptides Australia. FOX04-DRI is widely referenced in biochemical and cellular research for controlled experimental studies, valued for its high purity, stability, and reproducible performance in laboratory environments. Manufactured in accredited laboratories using advanced peptide synthesis methods, each FOX04-DRI vial is independently batch-tested to verify identity, purity, and consistency. Supplied as a 5mg lyophilised powder, FOX04-DRI provides professional researchers with a reliable, high-quality longevity & cellular research peptides compound for experimental work.

KEY FEATURES

• High-purity FOX04-DRI research peptide
• 5mg lyophilised powder per vial
• HPLC-MS verified purity (99.79%)
• Manufactured in accredited laboratories
• Sterile, tamper-evident vial suitable for laboratory handling
• Fast, discreet Australia-wide shipping

SPECIFICATIONS

Product Name

FOX04-DRI 5mg

Peptide Grade

Research Grade

Quantity

5mg per vial

Form

Lyophilised powder

Purity

99.79% (HPLC-MS tested)

Appearance

White/off-white lyophilised powder

Storage Conditions

Cool, dry environment; refrigeration recommended for long-term stability

Packaging

Sterile, tamper-evident research vial

WHY CHOOSE TITAN PEPTIDES

Titan Peptides is a trusted Australian supplier of premium research peptides. Every batch of FOX04-DRI undergoes rigorous HPLC-MS quality testing to verify purity, identity, and reproducibility — giving researchers the confidence required for accurate and controlled laboratory experiments. Orders ship same-day via Australia Post Express with discreet packaging.